Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10220240 | Gynecologic Oncology | 2018 | 5 Pages |
Abstract
There was no difference in inpatient pain scores between patients who received celecoxib or ketorolac as part of multimodal pain control following robotic hysterectomy. Patients who received scheduled celecoxib for seven days after surgery used less prescription narcotics.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Michael A. Ulm, Adam C. ElNaggar, Todd D. Tillmanns,